Furthermore, our data are in agreement with several published studies reporting associations in other patient groups such as rheumatoid arthritis [15] and chronic kidney disease [18], between CD4+CD28null T cells and markers of atherosclerotic damage. This evidence concerns the gene CD4 and rheumatoid arthritis.